A consensus guideline of herbal medicine for coronavirus disease 2019.

ABSTRACT:

Background

The Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2), which originated in Wuhan, Hubei Province, China in late December 2019, is the cause of ongoing pandemic. We analyzed the symptoms of SARS-CoV-2, a classification of the Chinese medicine dialectic and treatment regimen, and promptly enacted the recommendation of Korean medicine preparations in herbal medicine covered under domestic medical insurance benefits depending on the circumstances in our country.

Method

The clinical practice guideline (CPG) for the treatment of SARS-CoV-2 was developed based on consensus from a group of experts.

Results

Two kinds of herbal medicines (HM) were recommended for the prevention of SARS-CoV-2; Youngyopaedoc-san plus Bojungikgitang, and Youngyopaedoc-san plus

SUBMITTER: Lee BJ 

PROVIDER: S-EPMC7335489 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature